HN5-21209-18900 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-10
Dose 1 — Pfizer-BioNTech
Co-administered: HPV
2022-01-13
Registered in v-safe
2022-01-13
Dose 2 — Pfizer-BioNTech
Co-administered: Do not remember
2022-01-13
Health check-in — day 0, dose 2, dependent
Feeling: Good · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-01-13
Report sent to call center — day 0, dose 2, dependent
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-15
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Site: Pain · Fever · Chills, Headache, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-01-15
Report sent to call center — days 1–6 daily, dose 2, dependent
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-16
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Fever · None

Adult check-in
2022-01-17
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Fever · None

Adult check-in
2022-01-17
Call 1 — Left Voicemail
2022-01-18
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Site: Pain · Fever · Headache · Be unable to work or attend school

Adult check-in
2022-01-22
Health check-in — day 7, dose 2, dependent
Feeling: Good · Fever · None

Adult check-in
2022-02-02
Survey response — day 14, dose 2, dependent
MedDRA: Unevaluable event — Feeling: Good

Free text: (b)(6) hey

MedDRA releases: 2024-11 · check-in free text available
2022-02-05
Survey response — day 21, dose 2, dependent
MedDRA: Unevaluable event — Feeling: Good

Free text: Hey

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-10	Pfizer-BioNTech	HPV
2	2022-01-13	Pfizer-BioNTech	Do not remember

Call center

Reported	Outcome	VAERS-related outcome
2022-01-13	Unsuccessful
2022-01-15	Unsuccessful

Free text

Release 11 — day 14, dose 2, dependent

2022-02-02

Symptoms: (b)(6) hey

redacted (b)(6)

Release 11 — day 21, dose 2, dependent

2022-02-05

Symptoms: Hey

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release